5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.16▼ | 3.16▼ | 3.17▼ | 3.27▼ | 3.17▼ |
MA10 | 3.16▼ | 3.19▼ | 3.21▼ | 3.26▼ | 3.48▼ |
MA20 | 3.17▼ | 3.22▼ | 3.27▼ | 3.24▼ | 3.86▼ |
MA50 | 3.19▼ | 3.29▼ | 3.28▼ | 3.51▼ | 3.36▼ |
MA100 | 3.23▼ | 3.28▼ | 3.23▼ | 3.88▼ | 2.91▲ |
MA200 | 3.29▼ | 3.23▼ | 3.26▼ | 3.52▼ | 3.58▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.007▼ | -0.017▼ | 0.026▲ | -0.158▼ |
RSI | 36.190▼ | 30.958▼ | 33.093▼ | 43.297▼ | 42.760▼ |
STOCH | 43.750 | 16.706▼ | 9.674▼ | 51.340 | 9.609▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -75.520▼ | -92.283▼ |
CCI | -83.138 | -155.556▼ | -121.033▼ | -62.134 | -72.979 |
Friday, June 13, 2025 08:43 PM
Protara Therapeutics shows progress with TARA-002 in bladder cancer and strong financials, despite slow pipeline updates. Read more on TARA stock here.
|
Monday, May 26, 2025 05:00 PM
This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.
|
Tuesday, May 13, 2025 05:01 PM
Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript May 14, 2025 Allurion Technologies Inc. beats earnings expectations. Reported EPS is $0.43, expectations were $-1.53 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 3.22 | 3.27 | 3.12 | 3.14 | 165,447 |
12/06/25 | 3.43 | 3.458 | 3.24 | 3.26 | 210,611 |
11/06/25 | 3.38 | 3.5102 | 3.27 | 3.29 | 172,535 |
10/06/25 | 3.32 | 3.395 | 3.24 | 3.39 | 303,945 |
09/06/25 | 3.50 | 3.50 | 3.26 | 3.27 | 263,628 |
06/06/25 | 3.15 | 3.43 | 3.15 | 3.335 | 363,303 |
05/06/25 | 3.22 | 3.27 | 3.12 | 3.12 | 173,245 |
04/06/25 | 3.28 | 3.34 | 3.20 | 3.22 | 125,439 |
03/06/25 | 3.33 | 3.33 | 3.21 | 3.28 | 258,249 |
02/06/25 | 3.08 | 3.36 | 3.08 | 3.30 | 413,375 |
|
|
||||
|
|
||||
|
|